Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Msci Innovation UCITS ETF 1c

IE0006FFX5U1 · IE0006FFX5U1 · USD · domicile Ireland
Equity · Global · All sizes · Sustainable / ESG · ThematicSFDR art. 8
Index tracked: MSCI ACWI IMI Innovation Select Screened 200 Index (USD)
TER
0.30%+ trans. 0.16%
Fund size
6 m EUR
Tracking difference
−0.31%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Accumulating
Launch 12 Jul 2022 · costs from the KID as of 2 Sept 2026 · 195 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to track the performance before fees and expenses of MSCI ACWI IMI Innovation Select Screened 200 Index (index). DESCRIPTION OF INDEX: The index is based on the MSCI ACWI IMI Innovation Index (Parent Index) and reflects the performance of large, medium, and small-capitalisation companies globally that are expected to derive significant revenues from technological innovation. Companies from the Parent Index that pass both thematic selection criteria and ESG screening…

Performance since series start (in euro) — base 100

12 Jul 20228 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202320242025202617289169
High 172 (27 Aug 2026) · low 89 (29 Dec 2022) · last 169. Past performance is not indicative of future results.

Returns in euro

1 year+18.0%
3 years+53.5%
5 yearsseries too young
10 yearsseries too young
Since series start+69.2%

Risk · 1 / 3 / 5 years

Volatility (ann.)16.39%16.91%
Max drawdown−16.18%−20.11%
Sharpe0.880.87
Sortino1.281.27
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE0006FFX5U1 · IE0006FFX5U11
RebalixIE0006FFX5U1 · IE0006FFX5U1 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+14.67%+14.96%−0.29%
2024+21.87%+22.11%−0.24%
2023+32.18%+32.59%−0.40%

Holdings

Portfolio as declared by the issuer · 2 Sept 2026 · 195 securities · top-10 weight = 41.3%
Top holdingsWeight
MICROSOFT4.7%
APPLE4.7%
VISA CLASS A4.6%
MASTERCARD CLASS A4.6%
NVIDIA4.5%
VERTEX PHARMACEUTICALS4.5%
ROCHE PS PAR AG4.1%
TAIWAN SEMICONDUCTOR MANUFACTURING3.4%
MODERNA3.2%
AMAZON COM INC3.2%
Countries (% of fund)
United States76.7%Switzerland6.9%China5.5%Taiwan3.9%Brazil2.6%
Sectors (% of fund)
Information Technology37.8%Health Care27.9%Financials16.9%Consumer Discretionary9.5%Communication Services5.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
XNNV · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 7 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/4621aa95-c865-4876-b0f1-4a73cf1572ae
Factsheet · etf.dws.com/download/asset/2cd7011d-3513-4c39-ba6c-294ccd1256fb
Prospectus · etf.dws.com/download/asset/25f159fa-a123-4a77-9751-682976c15095
The live sheet, always up to date
rebalix.com/en/etf/IE0006FFX5U1
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IE0006FFX5U1 · IE0006FFX5U12